snc logo
AI Search Beta
Search Limit Reached
To ensure smooth performance and fair access for all users, AI searches are limited within a set timeframe. Please try again later.
Companies
Add Entity
snc-logo

Startup Nation Finder

My Watchlists
Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
Saved Searches
Following
Messaging
Notifications
About Us
Glossary

Your CSV is on the way

We’ve sent your CSV file to
send file

Provide your business email

To complete this action, please provide your Business email.

Verify your business email

You only need to verify it once.
We’ve sent a verification link to

Create Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
0/300
Notifications Settings
Public content (accessible by all Finder users)

Add to List

    Notifications settings

    Set Notifications
    Off
    Select notifications to recieve tooltip-info
    Select all

    Email Alerts

    Receive notifications via email

    No Notifications are selected

    Would you like to select any notifications?
    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Create Free Account
    Lock Icon
    Lock Icon
    8 Characters, Uppercase letter (A-Z),
    Lowercase letter (a-z), Digit (0-9)
    Lock Icon
    Passwords do not match
    Already have an account? Sign In
    Or continue with

    Verify your email

    We’ve sent a verification link to [email protected]
    Sign in
    Lock Icon
    Lock Icon
    Reset password
    Don't have an account? Create Account
    Or continue with

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    disclaimer-icon
    Summary generated by AI
    Read article
    snackbar-icon
    title
    message
    Search Startups

    Tagged as ('antibodies') Startups

    Filters
    Clear

    Search by tag (1)

    All of
    Any of
    None of

    Sector 

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage 

    Founded 

    From
    To

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models 

    Product Stage 

    Employees 

    Location 

    Status 
    Processing your search... This may take a moment
    32 Startups 4 In the News 4 Recently Updated
    • Total Funding
      $578.77M
      Raised
      54
      Events
    • Private Funding
      $110.03M
      Raised
      31
      Rounds
    • Public Offerings
      $368.74M
      Raised
      20
      Offerings
    • M&A
      $100M
      Raised
      3
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags
    Chemomab Therapeutics logo

    Chemomab Therapeutics

    Public
    Innovative Treatments for Patients with Fibro-Inflammatory-Related Diseases
    2011 B2B 11-50 Public $90.5M
    pharmaceuticals
    autoimmune-diseases
    immunology
    drug-delivery
    drug-discovery
    healthcare-providers
    treatments
    antibodies
    biopharmaceutical
    Compugen logo

    Compugen

    Public
    Drug Discovery Using Computational Modeling
    1993 B2B 51-200 Public $141.92M
    immunology
    oncology
    biotechnology
    bioinformatics
    antibodies
    drug-discovery
    proteins
    pharmaceuticals
    immunotherapy
    cancer-therapy
    autoimmune-diseases
    patients
    pharma-companies
    cancer
    Protalix BioTherapeutics logo

    Protalix BioTherapeutics

    Public
    Plant-based Proteins with Improved Therapeutic Profiles
    1994 B2B 51-200 Public $159.9M
    antibodies
    oral-drugs
    pharmaceuticals
    proteins
    genetic-disorders
    plant-protein
    inflammatory-diseases
    pharma-companies
    drug-development
    Purple Biotech logo

    Purple Biotech

    Public
    Tumor-immune Evasion and Drug Resistance Therapies
    1968 B2B 11-50 Public $91.54M
    immunotherapy
    antibodies
    pharmaceuticals
    oncology
    cancer
    cancer-therapy
    drug-development
    Adar Biotech logo

    Adar Biotech

    Drug Delivery Device
    2006 B2B, B2G 1-10 Mature Undisclosed
    drug-delivery
    dental
    manufacturing
    laboratories
    medical-devices
    immunology
    biotechnology
    genetics
    academia
    homeland-security
    antibodies
    Alomone Labs logo

    Alomone Labs

    Ion Channel Antibodies and Associated Modulators
    1989 B2B 11-50 Mature Undisclosed
    biotechnology
    antibodies
    laboratories
    healthcare-providers
    hospitals
    Applied Immune Technologies logo

    Applied Immune Technologies

    PRESUMED INACTIVE
    TCRL Antibodies for Therapeutic Applications
    2006 B2B 1-10 Acquired $4.4M
    viral-diseases
    cancer
    antibodies
    biotechnology
    biopharmaceutical
    therapeutics
    diagnostics
    autoimmune-diseases
    patients
    doctors
    Processing your search... This may take a moment
    Startup AI Search Beta
    Search notes

    Search Startups

    32 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $578.77M
      Raised
      54
      Events
    • Private Funding
      $110.03M
      Raised
      31
      Rounds
    • Public Offerings
      $368.74M
      Raised
      20
      Offerings
    • M&A
      $100M
      Raised
      3
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    Chemomab Therapeutics logo
    Raised
    $90.5M
    Chemomab Therapeutics
    Public
    Innovative Treatments for Patients with Fibro-Inflammatory-Related Diseases
    Founded:2011
    Business Model:B2B
    Employees:11-50
    Funding Stage:Public
    Compugen logo
    Raised
    $141.92M
    Compugen
    Public
    Drug Discovery Using Computational Modeling
    Founded:1993
    Business Model:B2B
    Employees:51-200
    Funding Stage:Public
    Protalix BioTherapeutics logo
    Raised
    $159.9M
    Protalix BioTherapeutics
    Public
    Plant-based Proteins with Improved Therapeutic Profiles
    Founded:1994
    Business Model:B2B
    Employees:51-200
    Funding Stage:Public
    Purple Biotech logo
    Raised
    $91.54M
    Purple Biotech
    Public
    Tumor-immune Evasion and Drug Resistance Therapies
    Founded:1968
    Business Model:B2B
    Employees:11-50
    Funding Stage:Public
    Adar Biotech logo
    Raised
    Undisclosed
    Adar Biotech
    Drug Delivery Device
    Founded:2006
    Business Model:B2B, B2G
    Employees:1-10
    Funding Stage:Mature
    Alomone Labs logo
    Raised
    Undisclosed
    Alomone Labs
    Ion Channel Antibodies and Associated Modulators
    Founded:1989
    Business Model:B2B
    Employees:11-50
    Funding Stage:Mature
    Applied Immune Technologies logo
    Raised
    $4.4M
    Applied Immune Technologies
    PRESUMED INACTIVE
    TCRL Antibodies for Therapeutic Applications
    Founded:2006
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    Access Comprehensive Financial Analytics
    Create a free account to:
    • Explore detailed financial analytics.
    • Track company growth and size.
    • Connect with company team members.
    I already have access,
    I already have access,